Catheter ablation was not the first-line treatment for supraventricular tachycardia (SVT) for most patients referred to a tertiary center, a study shows, with investigators suggesting the procedure is ...

Stereotaxis plans to launch the MAGiC cardiac ablation catheter in early 2026, CEO and Chair David Fischel tells MassDevice.

Stereotaxis CEO David Fischel says the MAGiC catheter was designed "to overcome the natural limitations of manual pull-wire ...

Stereotaxis’ CEO said the company has been “hampered clinically, commercially and strategically” by its prior dependence on a ...

Chloe Dygert revealed that she recently underwent a procedure to treat heart arrhythmia. The U.S. Olympic medalist confirmed doctors carried out a cardiac ablation to treat supraventricular ...

WALTHAM, Mass.--(BUSINESS WIRE)--Thermedical ®, a developer of thermal-ablation systems to treat ventricular arrhythmias, announced today that the U.S. Food & Drug Administration (FDA) has approved an ...

A new multicenter trial has used a new ablation technique for patients with ventricular tachycardia, an abnormally rapid heart rhythm that is a leading cause of sudden cardiac death worldwide. A first ...

WALTHAM, Mass.--(BUSINESS WIRE)--Thermedical ®, a developer of thermal-ablation systems to treat ventricular arrhythmias, announced today it has received $3 million in grant funding (1R44HL169112) ...

Intramural needle ablation using in-catheter, heated saline-enhanced radiofrequency was effective in reducing ventricular tachycardia burden for high-risk patients failing one to five prior ablations ...

Heart arrhythmias are usually harmless, but some can be life threatening. Treatments help correct your heart rate to prevent serious health issues. When the electrical impulses that affect your ...

Stereotaxis has won FDA approval for the MAGiC Magnetic Interventional Ablation Catheter. The device is a robotically ...